![Health / Pharmaceutical sciences / Drug discovery / Orphan drug / Clinical research / Rare disease / Biologic / Multitier architecture / Orphan Drug Act / Pharmacology / Pharmaceuticals policy / Health economics Health / Pharmaceutical sciences / Drug discovery / Orphan drug / Clinical research / Rare disease / Biologic / Multitier architecture / Orphan Drug Act / Pharmacology / Pharmaceuticals policy / Health economics](https://www.pdfsearch.io/img/fc97f67d57c4548f4a5fb819a6275110.jpg)
| Document Date: 2013-09-26 15:17:12 Open Document File Size: 277,88 KBShare Result on Facebook
City Washington / DC / / Country United States / / Currency USD / / / Facility Cannon House Office Building / / / IndustryTerm healthcare costs / co-insurance requirement / orphan products / co-insurance rate / therapies for all rare disorders / / MedicalCondition rare diseases / rare disorders / rare disease / / Organization National Organization for Rare Disorders / / / Position Peter L. Saltonstall President and CEO / / ProgrammingLanguage DC / / Technology diagnostic tests / /
SocialTag |